Logo image
Aerosol Delivery of Antibiotics to the Lower Airways of Patients With Cystic Fibrosis
Journal article   Peer reviewed

Aerosol Delivery of Antibiotics to the Lower Airways of Patients With Cystic Fibrosis

Stanley B. Fiel
Chest, v 107(2), pp 61S-64S
Feb 1995
PMID: 7842815

Abstract

aerosol antibiotics aminoglycosides cystic fibrosis respiratory infection
Aerosolized tobramycin is well tolerated in children and adults with cystic fibrosis (CF). It represents a potential alternative to intravenous administration of antibiotics to control respiratory infection with Pseudomonas aeruginosa. Although its exact role in acute therapy for a CF exacerbation is not known, it has been shown to improve lung function and reduce the frequency of exacerbations in the chronic stable outpatient.

Metrics

3 Record Views
25 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Critical Care Medicine
Respiratory System
Logo image